Идёт набор NCT06743308

Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer

Без фазы С лечением Lung Carcinoma Metastatic Lung Carcinoma Stage IV Lung Cancer AJCC v8

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают: В протоколе указаны: Best Practice, Questionnaire Administration.
Кому может быть актуально: Состояния в реестре: Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8. Базовые параметры: от 18 лет · Все.
Что важно проверить: Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится: США
Следующий шаг: Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Information Needs, Preferences, and Understanding Trial (INPUT): A Randomized, Controlled Trial of the Effects of a Screening Tool on Illness Understanding

Обзор

This clinical trial compares the use of a new screening tool designed to evaluate patients' information needs, preferences, and illness understanding to the usual care to improve illness understanding in patients with lung cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or for which no curative treatment is currently available (incurable). Goal concordant care is a model of care that aligns a patient's medical care with their values, preferences, and goals. Often, patients may not fully understand their illness and prognosis, but this information is important so that they can make fully informed decisions regarding their care that are consistent with their values, preferences, and goals. Completing the Information Needs, Preferences, and Understanding Trial (INPUT) screening tool may allow for more frequent and regular discussions regarding disease status and treatment goals, ultimately resulting in improved patient illness understanding and goal concordant care for patients with metastatic or incurable lung cancer.

Подробное описание

Primary Objectives To estimate the within group effect of perception of curability over 3 months in both the systematic screening group and the usual care group among patients with metastatic or incurable lung cancer who present to the thoracic medical oncology clinic at The University of Texas MD Anderson Cancer Center.

Вмешательства

Другое Best Practice
Other Best Practice best practice, standard of care, standard of care, standard of care, standard therapy Undergo standard of care oncology follow-up visits
Другое Questionnaire Administration
Ancillary studies

Первичные конечные точки

Change in illness understanding [Срок оценки: At 3 months]

Вторичные конечные точки (10)

Difference between treatment groups in illness understanding [Срок оценки: At 3 and 6 months]
Quality of communication [Срок оценки: At 3 and 6 months]
Feeling heard and understood by healthcare team [Срок оценки: At 3 and 6 months]
Death-related anxiety [Срок оценки: At 3 and 6 months]
Anxiety related symptoms [Срок оценки: At 3 and 6 months]
Depression [Срок оценки: At 3 and 6 months]
Health related quality of life [Срок оценки: At 3 and 6 months]
Symptoms of advanced cancer [Срок оценки: At 3 and 6 months]
Acceptability of screening tool [Срок оценки: At 3 months]
Goals of care [Срок оценки: At 3 and 6 months]

Критерии участия

Критерии включения

Within 3 months of biopsy-confirmed diagnosis of stage IV lung cancer
Age 18 or over
English speaking
Attending a follow-up visit at the thoracic medical oncology clinic
Plans to receive or actively undergoing cancer-directed systemic treatment at MD Anderson